For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
The Washington Post
FDA Promises to Move to Ban Menthol in Cigarettes, Flavored Cigars Within a Year
The Washington Post cites Senior Fellow Michelle Minton on menthol cigarettes: The Competitive Enterprise Institute, a libertarian think tank, warned that…
Blog
CDC Says It Is Safe for Vaccinated People to Unmask Outdoors
After much anticipation, the Centers for Disease Control and Prevention (CDC) has finally relaxed its guidelines on mask wearing—people who have been vaccinated…
Blog
A Menthol Cigarette Ban Would Perpetuate the Racist War on Drugs
In April the White House announced an apparently historic shift in the U.S. War on Drugs—away from strict prohibition to an approach emphasizing…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly,…
C-SPAN
VIDEO: CEI’s Joel Zinberg joins C-SPAN to Discuss Vaccine Passports and Mandates
Senior Fellow Joel Zinberg joined C-SPAN to discuss the debate over COVID-19 vaccine passports and the role of government and the private sector:…
New York Post
The Feds’ Foolish J&J Vax Pause is Already Undermining the War on COVID
A little more than a week ago, federal officials called for a pause in the use of Johnson & Johnson’s COVID-19 vaccine. The decision…